Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05498662 · ClinicalTrials.gov registry record

An Observational Study of the T3 Pro Dental Implant System

A clinical trial of Tooth Loss, sponsored by ZimVie.

Recruiting
Registry status
60
Enrollment target
2
Study locations

NCT05498662: Recruiting study of Tooth Loss, sponsored by ZimVie.

NCT05498662 is a study of Tooth Loss that is actively recruiting participants, run by ZimVie. The registered enrollment target is 60 participants, below the 99-participant average among 11 other Tooth Loss trials with a reported enrollment target (39% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05498662, a study of Tooth Loss, is actively recruiting participants, sponsored by ZimVie.

RECRUITING
Registry status
60 participants
Enrollment target
2
Study locations

Study Summary

A prospective, observational, multicenter study where 60 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.

Primary Outcome

the lack of implant mobility observed during 2 years duration; primary stability of the implant reached during implant placement as measured by placement torque and Resonance Frequency measures

Conditions Studied

Interventions

  • DEVICE T3 Pro dental implant system

Study Locations (2)

Louisiana

  • Louisiana State University Health Sciences Center - New Orleans

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-09-08
Est. Completion 2026-12-30
ZimVie

10 total trials

What NCT05498662 shows while recruiting

NCT05498662 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 99-participant average among 11 other Tooth Loss trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which T3 Pro dental implant system is the first listed.

NCT05498662 reports a single indexed study location in Louisiana, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05498662 about?

NCT05498662 is a clinical study titled "An Observational Study of the T3 Pro Dental Implant System". A prospective, observational, multicenter study where 60 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations year...

What is the current status of trial NCT05498662?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2022-09-08. Estimated completion is 2026-12-30.

What conditions does trial NCT05498662 study?

This clinical trial studies the following conditions: Tooth Loss.

What interventions are being tested in trial NCT05498662?

The interventions under investigation include: T3 Pro dental implant system (DEVICE).

Who is sponsoring clinical trial NCT05498662?

This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05498662 being conducted?

This trial has 2 study locations across Louisiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tooth Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05498662's enrollment target sits among peer trials

60 4th of 11 higher than 8 of 11 other Tooth Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tooth Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05498662, the US trial registry maintained by the National Library of Medicine. NCT05498662 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.